Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug
If your email program has trouble displaying this email, view it as a web page |
U.S. Food and Drug Administration |
Comments
Post a Comment